,18 The increased MDR/RR-TB risk among people with advanced HIV disease shown here is consistent with data from small case series, predominantly drawn from clinical trials, which have identified low CD4 cell counts (less than 100 cells/μl) at TB treatment start as an important risk factor for the subsequent emergence of MDR/RR-TB.9 This evidence concerns the gene CD4 and tuberculosis.